Mikhaylovsk (RU) Cancer Clinical Trials

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

~85 mi. (Yekaterinburg, Russia, +93 more cities)

Sverdlovsk Regional Oncology Hospital ( Site 0867), +1 more facility

Bladder Carcinoma, +1 more condition

cisplatin, +4 more drugs

chemotherapy, +3 more types

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

~85 mi. (Yekaterinburg, Russia, +163 more cities)

Sverdlovsk Regional Oncology Hospital ( Site 0874)

Bladder Urothelial Carcinoma

cystectomy, +2 more drugs

chemotherapy, +3 more types

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

~85 mi. (Yekaterinburg, Russia, +158 more cities)

Sverdlovsk Regional Oncology Hospital ( Site 1909)

Non-Small Cell Lung Carcinoma

olaparib, +4 more drugs

chemotherapy, +3 more types

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

~85 mi. (Yekaterinburg, Russia, +122 more cities)

Sverdlovsk Regional Oncology Hospital ( Site 1807)

Small Cell Lung Carcinoma

etoposide, +5 more drugs

chemotherapy, +3 more types

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

~85 mi. (Yekaterinburg, Russia, +126 more cities)

Sverdlovsk Regional Oncology Hospital ( Site 0411)

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

FOLFOX regimen, +3 more drugs

chemotherapy, +2 more types

Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)

~85 mi. (Yekaterinburg, Russia, +145 more cities)

Sverdlovsk Regional Oncology Hospital ( Site 2012)

Non-Small Cell Lung Carcinoma

pembrolizumab, +1 more drug

immunotherapy, +2 more types

A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

~85 mi. (Yekaterinburg, Russia, +108 more cities)

Sverdlovsk Regional Clinical Hospital #1